Literature DB >> 16332349

Calcium phosphate cements: competitive drug carriers for the musculoskeletal system?

Maria-Pau Ginebra1, Tania Traykova, Josep A Planell.   

Abstract

This paper attempts to provide an insight in the application of calcium phosphate cements (CPC) in the field of drug delivery devices for the musculoskeletal system. Their ability to set once implanted within the body, giving a highly microporous material, allows incorporation of many types of drugs and biologically active molecules, without losing activity and denaturalization. Additionally, by being injectable these materials can be used in the growing market for new technologies of minimally invasive surgery, and in the treatment of difficult accessible sites. All these characteristics, together with the excellent biological behaviour of CPC, make them good candidates for drug delivery devices to be used in the pharmacological treatment of a great number of diseases of the bone tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16332349     DOI: 10.1016/j.biomaterials.2005.11.023

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  22 in total

Review 1.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

2.  In vivo evaluation of an injectable Macroporous Calcium Phosphate Cement.

Authors:  Sergio del Valle; Natalia Miño; Fernando Muñoz; Antonio González; Josep A Planell; Maria-Pau Ginebra
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

Review 3.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

4.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

5.  The biocompatibility of calcium phosphate cements containing alendronate-loaded PLGA microparticles in vitro.

Authors:  Yu-Hua Li; Zhen-Dong Wang; Wei Wang; Chang-Wei Ding; Hao-Xuan Zhang; Jian-Min Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-14

Review 6.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

Review 7.  Therapeutic actions of curcumin in bone disorders.

Authors:  Ramin Rohanizadeh; Yi Deng; Elise Verron
Journal:  Bonekey Rep       Date:  2016-03-02

8.  Simvastatin-doped pre-mixed calcium phosphate cement inhibits osteoclast differentiation and resorption.

Authors:  M Montazerolghaem; A Rasmusson; H Melhus; H Engqvist; M Karlsson Ott
Journal:  J Mater Sci Mater Med       Date:  2016-03-11       Impact factor: 3.896

9.  Lovastatin release from polycaprolactone coated β-tricalcium phosphate: effects of pH, concentration and drug-polymer interactions.

Authors:  Solaiman Tarafder; Kelly Nansen; Susmita Bose
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-03-14       Impact factor: 7.328

Review 10.  Calcium orthophosphates: occurrence, properties, biomineralization, pathological calcification and biomimetic applications.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.